VF
CNTB

Virtu Financial’s Connect Biopharma Holdings CNTB Stock Holding History

Virtu Financial’s Portfolio CNTB Stock Details CNTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$44K Buy
+16,914
New +$44.1K ﹤0.01% 1307
2022
Q3 		– Sell
-16,658
Closed -$14K – 1790
2022
Q2 		$14K Buy
+16,658
New +$24.5K ﹤0.01% 1385

Other funds holding CNTB

IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
RB
Richmond Brothers Jackson, Michigan $150M AUM 14.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
BML Capital Management Zionsville, Indiana $156M AUM 129.82% 1-Year Est. Return
DMKJ
David M. Knott Jr $168M AUM 60.36% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Virtu Financial's CNTB Position: Q1 2026 in Review

Virtu Financial opened a new position in Connect Biopharma Holdings (CNTB) in Q1 2026: 16,914 shares worth $44K. The stake represents ﹤0.01% of the portfolio and ranks #1307 among its holdings. This is a return to the name: Virtu Financial previously reported a position in CNTB as recently as Q2 2022.

Virtu Financial first reported a position in CNTB in Q2 2022 and has held it in 2 quarters since. 41 funds tracked by Wall St. Rank hold CNTB as of Q1 2026.

  • Virtu Financial held 16,914 shares of Connect Biopharma Holdings worth $44K as of Q1 2026.
  • Connect Biopharma Holdings was a new Virtu Financial position in Q1 2026.
  • Connect Biopharma Holdings made up ﹤0.01% of Virtu Financial's portfolio in Q1 2026, its #1307 holding.
  • Virtu Financial first reported a position in Connect Biopharma Holdings in Q2 2022 and has held it in 2 quarters since.
  • 41 funds tracked by Wall St. Rank held Connect Biopharma Holdings as of Q1 2026.

Based on Virtu Financial's 13F filing for Q1 2026, filed 14 May 2026.